Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prions | 22 | 2019 | 53 | 2.730 |
Why?
|
| Prion Diseases | 15 | 2023 | 31 | 2.380 |
Why?
|
| Gerstmann-Straussler-Scheinker Disease | 11 | 2019 | 11 | 1.870 |
Why?
|
| PrPSc Proteins | 12 | 2021 | 21 | 1.630 |
Why?
|
| PrPC Proteins | 9 | 2021 | 13 | 1.630 |
Why?
|
| Plaque, Amyloid | 4 | 2019 | 69 | 1.550 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 646 | 1.380 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 208 | 0.930 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 31 | 0.740 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 10 | 2010 | 14 | 0.720 |
Why?
|
| Parkinson Disease | 2 | 2023 | 186 | 0.640 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2572 | 0.630 |
Why?
|
| Mice, Transgenic | 14 | 2021 | 1605 | 0.620 |
Why?
|
| Benzodioxoles | 1 | 2019 | 15 | 0.590 |
Why?
|
| Pyrazoles | 1 | 2019 | 160 | 0.540 |
Why?
|
| Amyloid beta-Peptides | 1 | 2019 | 250 | 0.520 |
Why?
|
| Brain | 12 | 2012 | 2429 | 0.440 |
Why?
|
| Parahippocampal Gyrus | 1 | 2013 | 4 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 33 | 0.400 |
Why?
|
| Mice | 19 | 2021 | 12707 | 0.360 |
Why?
|
| Sirolimus | 1 | 2012 | 182 | 0.340 |
Why?
|
| Cytosol | 2 | 2010 | 193 | 0.320 |
Why?
|
| Animals | 29 | 2021 | 28910 | 0.310 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2010 | 102 | 0.300 |
Why?
|
| Prion Proteins | 6 | 2018 | 9 | 0.290 |
Why?
|
| Mutation, Missense | 1 | 2009 | 302 | 0.260 |
Why?
|
| Wasting Disease, Chronic | 2 | 2021 | 2 | 0.260 |
Why?
|
| Deer | 2 | 2021 | 5 | 0.260 |
Why?
|
| Zoonoses | 2 | 2021 | 29 | 0.250 |
Why?
|
| Phenotype | 9 | 2018 | 2638 | 0.250 |
Why?
|
| Clonidine | 5 | 1989 | 33 | 0.220 |
Why?
|
| Dementia | 4 | 2010 | 226 | 0.210 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2005 | 93 | 0.210 |
Why?
|
| Endopeptidase K | 2 | 2019 | 12 | 0.210 |
Why?
|
| Sclerosis | 1 | 2003 | 30 | 0.200 |
Why?
|
| Point Mutation | 2 | 2001 | 237 | 0.190 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2005 | 154 | 0.190 |
Why?
|
| Gene Expression | 2 | 2006 | 1320 | 0.190 |
Why?
|
| Ataxia | 2 | 2009 | 45 | 0.190 |
Why?
|
| Equipment Contamination | 1 | 2002 | 28 | 0.180 |
Why?
|
| Iatrogenic Disease | 1 | 2002 | 70 | 0.180 |
Why?
|
| Hippocampus | 2 | 2003 | 462 | 0.180 |
Why?
|
| Protein Precursors | 2 | 2000 | 133 | 0.180 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 137 | 0.180 |
Why?
|
| Amyloid | 2 | 2000 | 104 | 0.180 |
Why?
|
| Surgical Instruments | 1 | 2002 | 69 | 0.180 |
Why?
|
| Disease Progression | 4 | 2018 | 1609 | 0.150 |
Why?
|
| Family Health | 1 | 2000 | 156 | 0.150 |
Why?
|
| Humans | 31 | 2023 | 97893 | 0.150 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2020 | 104 | 0.150 |
Why?
|
| Aged | 13 | 2023 | 21701 | 0.140 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2020 | 262 | 0.140 |
Why?
|
| Receptors, Opioid | 2 | 1989 | 23 | 0.140 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 402 | 0.140 |
Why?
|
| Genotype | 4 | 2010 | 1888 | 0.140 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 66 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 2892 | 0.120 |
Why?
|
| Rats, Inbred SHR | 5 | 1989 | 33 | 0.120 |
Why?
|
| Rats, Inbred Strains | 5 | 1989 | 300 | 0.120 |
Why?
|
| Male | 21 | 2020 | 46995 | 0.120 |
Why?
|
| Mutation | 7 | 2010 | 4396 | 0.120 |
Why?
|
| Biological Assay | 1 | 2016 | 82 | 0.110 |
Why?
|
| tau Proteins | 2 | 2011 | 104 | 0.110 |
Why?
|
| Inclusion Bodies | 2 | 2012 | 31 | 0.110 |
Why?
|
| Neuroblastoma | 3 | 2008 | 409 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2009 | 780 | 0.110 |
Why?
|
| Thalamus | 2 | 2010 | 136 | 0.110 |
Why?
|
| Endorphins | 3 | 1989 | 13 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2010 | 303 | 0.110 |
Why?
|
| Blood Pressure | 4 | 1987 | 909 | 0.100 |
Why?
|
| Fasciculation | 1 | 1994 | 1 | 0.100 |
Why?
|
| Abducens Nerve | 1 | 1994 | 14 | 0.100 |
Why?
|
| Lyme Disease | 1 | 1994 | 9 | 0.100 |
Why?
|
| Ophthalmoplegia | 1 | 1994 | 12 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 177 | 0.100 |
Why?
|
| Protein Conformation | 3 | 2010 | 925 | 0.100 |
Why?
|
| Spinal Curvatures | 1 | 2013 | 8 | 0.100 |
Why?
|
| Female | 11 | 2019 | 51463 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2010 | 99 | 0.100 |
Why?
|
| Base Sequence | 4 | 2005 | 2222 | 0.100 |
Why?
|
| Time Factors | 3 | 2012 | 5555 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2013 | 66 | 0.090 |
Why?
|
| Neurofibrillary Tangles | 2 | 2011 | 49 | 0.090 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 7386 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 902 | 0.090 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2013 | 52 | 0.090 |
Why?
|
| Tunicamycin | 1 | 2012 | 11 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2016 | 0.090 |
Why?
|
| Random Allocation | 1 | 2012 | 311 | 0.090 |
Why?
|
| Hypertension | 3 | 1987 | 778 | 0.090 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 1989 | 33 | 0.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 304 | 0.080 |
Why?
|
| Analgesia | 2 | 1989 | 65 | 0.080 |
Why?
|
| Kuru | 1 | 2010 | 1 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 48 | 0.080 |
Why?
|
| Insomnia, Fatal Familial | 1 | 2010 | 3 | 0.080 |
Why?
|
| Protein Folding | 2 | 2010 | 291 | 0.080 |
Why?
|
| Injections, Intraventricular | 2 | 2006 | 19 | 0.080 |
Why?
|
| Brain Stem | 1 | 2010 | 167 | 0.080 |
Why?
|
| Benzothiazoles | 1 | 2009 | 19 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 642 | 0.070 |
Why?
|
| Fungal Proteins | 1 | 2010 | 148 | 0.070 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1989 | 17 | 0.070 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 340 | 0.070 |
Why?
|
| Heart Rate | 3 | 1987 | 534 | 0.070 |
Why?
|
| Thiazoles | 1 | 2009 | 126 | 0.070 |
Why?
|
| Cerebellum | 1 | 2010 | 253 | 0.070 |
Why?
|
| Transfection | 2 | 2008 | 883 | 0.070 |
Why?
|
| Bradycardia | 1 | 1989 | 51 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2012 | 2208 | 0.070 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 16 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 1567 | 0.070 |
Why?
|
| Protein Binding | 2 | 2010 | 1555 | 0.060 |
Why?
|
| Leupeptins | 1 | 2006 | 21 | 0.060 |
Why?
|
| Rats | 7 | 1989 | 4071 | 0.060 |
Why?
|
| DNA Mutational Analysis | 3 | 2010 | 548 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2006 | 52 | 0.060 |
Why?
|
| Circular Dichroism | 1 | 2006 | 118 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 1986 | 66 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1254 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 310 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 334 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 285 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 55 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 1998 | 2896 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 50 | 0.060 |
Why?
|
| Neurons | 3 | 2018 | 1619 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2008 | 2555 | 0.050 |
Why?
|
| Species Specificity | 5 | 2011 | 690 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2005 | 79 | 0.050 |
Why?
|
| Perfusion | 1 | 1986 | 271 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2005 | 207 | 0.050 |
Why?
|
| Heterozygote | 1 | 2005 | 390 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 2008 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 582 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 1986 | 267 | 0.050 |
Why?
|
| Tryptamines | 1 | 1983 | 2 | 0.050 |
Why?
|
| Middle Aged | 8 | 2011 | 29352 | 0.050 |
Why?
|
| Histological Techniques | 1 | 1983 | 33 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 3605 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2010 | 1445 | 0.050 |
Why?
|
| Catecholamines | 1 | 1983 | 93 | 0.050 |
Why?
|
| Risk Factors | 2 | 2011 | 6224 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3606 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 1999 | 295 | 0.040 |
Why?
|
| Prevalence | 1 | 2005 | 1384 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2005 | 1995 | 0.040 |
Why?
|
| Image Enhancement | 1 | 1983 | 503 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 831 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 55 | 0.040 |
Why?
|
| Naloxone | 3 | 1989 | 80 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2000 | 110 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 1999 | 103 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 1999 | 110 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 557 | 0.040 |
Why?
|
| Blood Component Transfusion | 1 | 1998 | 13 | 0.030 |
Why?
|
| Genetic Markers | 1 | 1999 | 471 | 0.030 |
Why?
|
| Adult | 6 | 2011 | 29453 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1998 | 12 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 1815 | 0.030 |
Why?
|
| Neuroglia | 1 | 2018 | 78 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1997 | 62 | 0.030 |
Why?
|
| Myoclonus | 1 | 1997 | 13 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1998 | 130 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 1998 | 59 | 0.030 |
Why?
|
| Hand | 1 | 1997 | 143 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1224 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 1998 | 257 | 0.030 |
Why?
|
| Jews | 1 | 1995 | 42 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 789 | 0.030 |
Why?
|
| Genetic Testing | 2 | 2010 | 594 | 0.030 |
Why?
|
| Pedigree | 1 | 1996 | 980 | 0.030 |
Why?
|
| Cricetinae | 3 | 1998 | 533 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 894 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 977 | 0.020 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2012 | 9 | 0.020 |
Why?
|
| Age of Onset | 2 | 2008 | 367 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 120 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1752 | 0.020 |
Why?
|
| Cardiovascular System | 2 | 1989 | 52 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1145 | 0.020 |
Why?
|
| Tyrosine | 1 | 2011 | 135 | 0.020 |
Why?
|
| Rats, Inbred WKY | 2 | 1987 | 31 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2011 | 73 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 525 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 448 | 0.020 |
Why?
|
| Glutamine | 1 | 2011 | 98 | 0.020 |
Why?
|
| DNA | 1 | 1995 | 1274 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2658 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 945 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 1989 | 4 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2011 | 136 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 1989 | 50 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 566 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2008 | 110 | 0.020 |
Why?
|
| Alanine | 1 | 2008 | 82 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2008 | 78 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 1989 | 340 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 259 | 0.020 |
Why?
|
| beta-Endorphin | 1 | 1987 | 9 | 0.020 |
Why?
|
| Yohimbine | 1 | 1987 | 6 | 0.020 |
Why?
|
| Prazosin | 1 | 1987 | 8 | 0.020 |
Why?
|
| Naltrexone | 1 | 1989 | 139 | 0.020 |
Why?
|
| Memory, Short-Term | 1 | 2011 | 257 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1987 | 82 | 0.020 |
Why?
|
| Mesocricetus | 2 | 1998 | 103 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 720 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1986 | 212 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1986 | 110 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 872 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1999 | 613 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1986 | 102 | 0.010 |
Why?
|
| Tachyphylaxis | 1 | 1985 | 14 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1985 | 59 | 0.010 |
Why?
|
| Equipment Design | 1 | 1986 | 425 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 669 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1989 | 1946 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 4112 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1983 | 16 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 161 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1776 | 0.010 |
Why?
|
| Fluorescence | 1 | 1983 | 100 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 273 | 0.010 |
Why?
|
| Primates | 1 | 1983 | 164 | 0.010 |
Why?
|
| Apolipoprotein C-I | 1 | 1999 | 2 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 1999 | 5 | 0.010 |
Why?
|
| Lod Score | 1 | 1999 | 152 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1999 | 110 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 1999 | 139 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1998 | 126 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 113 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 90 | 0.010 |
Why?
|
| Perceptual Disorders | 1 | 1997 | 14 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1998 | 114 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 7504 | 0.010 |
Why?
|
| Protons | 1 | 1997 | 102 | 0.010 |
Why?
|
| Atrophy | 1 | 1997 | 130 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1997 | 271 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 231 | 0.010 |
Why?
|
| Libya | 1 | 1995 | 3 | 0.010 |
Why?
|
| Life Tables | 1 | 1995 | 46 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1995 | 58 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 162 | 0.010 |
Why?
|
| Transgenes | 1 | 1995 | 173 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 1995 | 125 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 225 | 0.010 |
Why?
|
| Probability | 1 | 1995 | 356 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 2007 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1960 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1998 | 2680 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 10078 | 0.000 |
Why?
|